-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N7CGw7zGaGw9htXIoRYUKbWplU0NwInOw1wz7n4tCj45JWGDbgVqaeJcDnw0Cc67 BSyyLydYQ7EWXwx1P8WJxg== 0000893220-02-000865.txt : 20020703 0000893220-02-000865.hdr.sgml : 20020703 20020703144234 ACCESSION NUMBER: 0000893220-02-000865 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-62234 FILM NUMBER: 02696242 BUSINESS ADDRESS: STREET 1: 145 BRANDYWINE PKWY CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 145 BRANDYWINE PARKWAY CITY: WEST CHESTER STATE: PA ZIP: 19380 424B3 1 w62053e424b3.txt CEPHALON, INC. Prospectus Supplement No. 17 Filed pursuant to Rule 424(b)(3) to Prospectus dated August 6, 2001 File No. 333-62234 CEPHALON, INC. $400,000,000 5-1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2006 This document supplements information contained in that certain prospectus of Cephalon, Inc. dated August 6, 2001, as amended and supplemented from time to time, relating to the potential resale from time to time of $400,000,000 5-1/4% Convertible Subordinated Notes due 2006 and 5,405,405 shares of common stock by the selling securityholders identified in the prospectus and any prospectus supplements. This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with the prospectus, including any amendments or supplements thereto. The following table supplements, or amends, as noted, the information set forth in the prospectus under the caption "Selling Securityholders" with respect to: - the principal amount of notes beneficially owned by each selling securityholder and the maximum principal amount that each may offer, and - the number of shares of common stock issued upon conversion of the notes that each selling securityholder may sell under the prospectus, as amended or supplemented.
NUMBER OF COMMON SHARES ISSUED UPON PRINCIPAL AMOUNT OF NOTES CONVERSION THAT MIGHT BE NAME OF SELLING SECURITYHOLDER (1) BENEFICIALLY OWNED (2) SOLD - ---------------------------------- ---------------------- ------------------------ The following information supplements the information set forth in the prospectus originally filed or as previously amended or supplemented: Arbitex Master Fund L.P. 11,850,000 160,135 Lyxor Master Fund ref HW 2,300,000 31,081 The following information amends the information set forth in the prospectus originally filed or as previously amended or supplemented: Zurich Institutional Benchmarks Master Fund Ltd. 200,000 2,702 c/o TQA Investors, LLC*
(1) The information set forth herein is as of July 3, 2002 and will be updated as required. (2) Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. * This Selling Securityholder was originally listed in the prospectus under the name Zurich Institutional Benchmarks Master Fund Ltd. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense. The date of this prospectus supplement is July 3, 2002.
-----END PRIVACY-ENHANCED MESSAGE-----